Search
for
Sort by
Research 271–300 of 1000+
- Finasteride
- Adverse effects of common medications on male fertility
- Acne and Systemic Disease
- The control of hair growth: An overview
- Fadrozole and finasteride exposures modulate sex steroid- and thyroid hormone-related gene expression in Silurana (Xenopus) tropicalis early larval development
- The therapeutic use of androgens in women
- Endocrinologic Aspects of Hidradenitis Suppurativa
- Acquired scalp alopecia. Part I: A review
- Hirsutism: Diagnosis and management
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Hormonal changes in menopause: do they contribute to a ‘midlife hair crisis’ in women?
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles
- Factors associated with female pattern hair loss and its prevalence in Taiwanese women: A community-based survey
- The Clinical Presentation of Systemic Lupus Erythematosus
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Further Clinical Evidence for the Effect of IGF-1 on Hair Growth and Alopecia
- Clinical applications of antiandrogens
- Does a male polycystic ovarian syndrome equivalent exist?
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- What is the Rationale for Androgen Therapy for Women?
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Skin diseases in consequence of endocrine alterations
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment